Xiang Lin Tan

Summary

Affiliation: Mayo Clinic
Country: USA

Publications

  1. ncbi High-throughput library screening identifies two novel NQO1 inducers in human lung cells
    Xiang Lin Tan
    M D Department of Health Science Research, Mayo Clinic, 200 First Street S W, Rochester, MN 55905, USA
    Am J Respir Cell Mol Biol 46:365-71. 2012
  2. ncbi Candidate dietary phytochemicals modulate expression of phase II enzymes GSTP1 and NQO1 in human lung cells
    Xiang Lin Tan
    Division of Pulmonary Medicine, Albert Einstein College of Medicine, Bronx, NY, USA
    J Nutr 140:1404-10. 2010
  3. ncbi Aspirin, nonsteroidal anti-inflammatory drugs, acetaminophen, and pancreatic cancer risk: a clinic-based case-control study
    Xiang Lin Tan
    Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Cancer Prev Res (Phila) 4:1835-41. 2011
  4. ncbi Haplotype-tagging single nucleotide polymorphisms in the GSTP1 gene promoter and susceptibility to lung cancer
    Xiang Lin Tan
    Laboratory of Human Toxicology and Molecular Epidemiology, Wadsworth Center, New York State Department of Health, Albany, NY, USA
    Cancer Detect Prev 32:403-15. 2009
  5. ncbi Dietary chemoprevention strategies for induction of phase II xenobiotic-metabolizing enzymes in lung carcinogenesis: A review
    Xiang Lin Tan
    Division of Pulmonary Medicine, Department of Medicine, Albert Einstein College of Medicine, Bronx, NY, United States
    Lung Cancer 65:129-37. 2009
  6. ncbi Genetic variation predicting cisplatin cytotoxicity associated with overall survival in lung cancer patients receiving platinum-based chemotherapy
    Xiang Lin Tan
    Division of Clinical Pharmacology, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
    Clin Cancer Res 17:5801-11. 2011

Detail Information

Publications6

  1. ncbi High-throughput library screening identifies two novel NQO1 inducers in human lung cells
    Xiang Lin Tan
    M D Department of Health Science Research, Mayo Clinic, 200 First Street S W, Rochester, MN 55905, USA
    Am J Respir Cell Mol Biol 46:365-71. 2012
    ..These studies show that potency and low toxicity may align for two potential NQO1-inducing agents, DMEBP and TRES...
  2. ncbi Candidate dietary phytochemicals modulate expression of phase II enzymes GSTP1 and NQO1 in human lung cells
    Xiang Lin Tan
    Division of Pulmonary Medicine, Albert Einstein College of Medicine, Bronx, NY, USA
    J Nutr 140:1404-10. 2010
    ..We conclude that modulation of lung cell phase II metabolism by chemopreventive agents requires cell- and agent-specific discovery and testing...
  3. ncbi Aspirin, nonsteroidal anti-inflammatory drugs, acetaminophen, and pancreatic cancer risk: a clinic-based case-control study
    Xiang Lin Tan
    Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Cancer Prev Res (Phila) 4:1835-41. 2011
    ..Our data suggest that aspirin use, but not non-aspirin NSAID use, is associated with lowered risk of developing pancreatic cancer...
  4. ncbi Haplotype-tagging single nucleotide polymorphisms in the GSTP1 gene promoter and susceptibility to lung cancer
    Xiang Lin Tan
    Laboratory of Human Toxicology and Molecular Epidemiology, Wadsworth Center, New York State Department of Health, Albany, NY, USA
    Cancer Detect Prev 32:403-15. 2009
    ..The main objective of the current study was to test the association between GSTP1 promoter haplotypes with the risk of lung cancer after determining the promoter haplotypes experimentally through cloning and sequencing...
  5. ncbi Dietary chemoprevention strategies for induction of phase II xenobiotic-metabolizing enzymes in lung carcinogenesis: A review
    Xiang Lin Tan
    Division of Pulmonary Medicine, Department of Medicine, Albert Einstein College of Medicine, Bronx, NY, United States
    Lung Cancer 65:129-37. 2009
    ..These approaches may lead to a more effective strategy of tailored chemoprevention efforts using compounds with proven human activity...
  6. ncbi Genetic variation predicting cisplatin cytotoxicity associated with overall survival in lung cancer patients receiving platinum-based chemotherapy
    Xiang Lin Tan
    Division of Clinical Pharmacology, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
    Clin Cancer Res 17:5801-11. 2011
    ....